LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 1726

Search options

  1. Article: Evaluation of the feasibility of the FAST-M maternal sepsis intervention in Pakistan: a protocol.

    Ahmed, Sheikh Irfan / Sikandar, Raheel / Barolia, Rubina / Hanif Khowaja, Bakhtawar M / Memon, Kashif Ali / Cheshire, James / Dunlop, Catherine / Coomarasamy, Arri / Sheikh, Lumaan / Lissauer, David

    Pilot and feasibility studies

    2022  Volume 8, Issue 1, Page(s) 130

    Abstract: ... including the World Health Organization, developed a maternal sepsis management bundle called "FAST-M ... for resource-limited settings through a synthesis of evidence and international consensus. The FAST-M treatment ... neonate). This study aims to adapt the FAST-M intervention and evaluate its feasibility in Pakistan ...

    Abstract Background: Maternal sepsis is a life-threatening condition, defined by organ dysfunction caused by infection during pregnancy, childbirth, and the postpartum period. It is estimated to account for between one-tenth and half (4.7% to 13.7%) of all maternal deaths globally. An international stakeholder group, including the World Health Organization, developed a maternal sepsis management bundle called "FAST-M" for resource-limited settings through a synthesis of evidence and international consensus. The FAST-M treatment bundle consists of five components: Fluids, Antibiotics, Source identification and control, assessment of the need to Transport or Transfer to a higher level of care and ongoing Monitoring (of the mother and neonate). This study aims to adapt the FAST-M intervention and evaluate its feasibility in Pakistan.
    Methods: The proposed study is a mixed method, with a before and after design. The study will be conducted in two phases at the Liaquat University of Medical and Health Sciences, Hyderabad. In the first phase (formative assessment), we will adapt the bundle care tools for the local context and assess in what circumstances different components of the intervention are likely to be effective, by conducting interviews and a focus group discussion. Qualitative data will be analyzed considering a framework method approach using NVivo version 10 (QSR International, Pty Ltd.) software. The qualitative results will guide the adaptation of FAST-M intervention in local context. In the second phase, we will evaluate the feasibility of the FAST-M intervention. Quantitative analyses will be done to assess numerous outcomes: process, organizational, clinical, structural, and adverse events with quantitative comparisons made before and after implementation of the bundle. Qualitative analysis will be done to evaluate the outcomes of intervention by conducting FGDs with HCPs involved during the implementation process. This will provide an understanding and validation of quantitative findings.
    Discussion: The utilization of care bundles can facilitate recognition and timely management of maternal sepsis. There is a need to adapt, integrate, and optimize a bundled care approach in low-resource settings in Pakistan to minimize the burden of maternal morbidities and mortalities due to sepsis.
    Language English
    Publishing date 2022-06-24
    Publishing country England
    Document type Journal Article
    ZDB-ID 2809935-7
    ISSN 2055-5784
    ISSN 2055-5784
    DOI 10.1186/s40814-022-01090-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Early recognition and management of maternal sepsis in Pakistan: a feasibility study of the implementation of FAST-M intervention.

    Ahmed, Sheikh Irfan / Rind, Ghulam Kubra / Sikandar, Raheel / Raza, Amir / Khowaja, Bakhtawar M Hanif / Parveen, Fahmida / Khan, Sehrish / Memon, Nazia / Jahangir, Arshia / Mirza, Daayl Naim / Cheshire, James / Dunlop, Catherine Louise / Shakoor, Sadia / Barolia, Rubina / Sheikh, Lumaan / Saleem, Sarah / Coomarasamy, Arri / Lissauer, David

    BMJ open

    2023  Volume 13, Issue 7, Page(s) e069135

    Abstract: ... collaborators developed a care bundle called FAST-M (: Design and setting: A feasibility study ... recorded, followed by a training programme for healthcare providers on the application of FAST-M tools ... compared with the baseline phase.: Results: During the FAST-M implementation, 439 women were included ...

    Abstract Objective: Maternal sepsis is the third leading cause of maternal mortality globally. WHO and collaborators developed a care bundle called FAST-M (
    Design and setting: A feasibility study with before and after design was conducted in women with suspected maternal sepsis admitted at the Liaquat University of Medical and Health Sciences hospital Hyderabad. The study outcomes were compared between baseline and intervention phases. In the baseline phase (2 months), the existing sepsis care practices were recorded, followed by a training programme for healthcare providers on the application of FAST-M tools. These tools were implemented in the intervention phase (4 months) to assess any change in clinical practices compared with the baseline phase.
    Results: During the FAST-M implementation, 439 women were included in the study. 242/439 were suspected maternal infection cases, and 138/242 were women with suspected maternal sepsis. The FAST-M bundle was implemented in women with suspected maternal sepsis. Following the FAST-M intervention, significant changes were observed. Improvements were seen in the monitoring of oxygen saturation measurements (25.5% vs 100%; difference: 74%; 95% CI: 68.4% to 80.5%; p<0.01), fetal heart rate assessment (58% vs 100%; difference: 42.0%; 95% CI: 33.7% to 50.3%; p≤0.01) and measurement of urine output (76.5% vs 100%; difference: 23.5%; 95% CI: 17.6% to 29.4%; p<0.01). Women with suspected maternal sepsis received all components of the treatment bundle within 1 hour of sepsis recognition (0% vs 70.5%; difference: 70.5%; 95% CI: 60.4% to 80.6%; p<0.01).
    Conclusion: Implementation of the FAST-M intervention was considered feasible and enhanced early identification and management of maternal sepsis at the study site.
    Trial registration number: ISRCTN17105658.
    MeSH term(s) Female ; Humans ; Pregnancy ; Anti-Bacterial Agents/therapeutic use ; Feasibility Studies ; Pakistan ; Pregnancy Complications, Infectious/diagnosis ; Sepsis/diagnosis ; Sepsis/therapy ; Sepsis/etiology
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2023-07-30
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2599832-8
    ISSN 2044-6055 ; 2044-6055
    ISSN (online) 2044-6055
    ISSN 2044-6055
    DOI 10.1136/bmjopen-2022-069135
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Evaluation of the feasibility of the FAST-M maternal sepsis intervention in Pakistan

    Sheikh Irfan Ahmed / Raheel Sikandar / Rubina Barolia / Bakhtawar M. Hanif Khowaja / Kashif Ali Memon / James Cheshire / Catherine Dunlop / Arri Coomarasamy / Lumaan Sheikh / David Lissauer

    Pilot and Feasibility Studies, Vol 8, Iss 1, Pp 1-

    a protocol

    2022  Volume 12

    Abstract: ... FAST-M” for resource-limited settings through a synthesis of evidence and international consensus ... The FAST-M treatment bundle consists of five components: Fluids, Antibiotics, Source identification and ... of the mother and neonate). This study aims to adapt the FAST-M intervention and evaluate its feasibility ...

    Abstract Abstract Background Maternal sepsis is a life-threatening condition, defined by organ dysfunction caused by infection during pregnancy, childbirth, and the postpartum period. It is estimated to account for between one-tenth and half (4.7% to 13.7%) of all maternal deaths globally. An international stakeholder group, including the World Health Organization, developed a maternal sepsis management bundle called “FAST-M” for resource-limited settings through a synthesis of evidence and international consensus. The FAST-M treatment bundle consists of five components: Fluids, Antibiotics, Source identification and control, assessment of the need to Transport or Transfer to a higher level of care and ongoing Monitoring (of the mother and neonate). This study aims to adapt the FAST-M intervention and evaluate its feasibility in Pakistan. Methods The proposed study is a mixed method, with a before and after design. The study will be conducted in two phases at the Liaquat University of Medical and Health Sciences, Hyderabad. In the first phase (formative assessment), we will adapt the bundle care tools for the local context and assess in what circumstances different components of the intervention are likely to be effective, by conducting interviews and a focus group discussion. Qualitative data will be analyzed considering a framework method approach using NVivo version 10 (QSR International, Pty Ltd.) software. The qualitative results will guide the adaptation of FAST-M intervention in local context. In the second phase, we will evaluate the feasibility of the FAST-M intervention. Quantitative analyses will be done to assess numerous outcomes: process, organizational, clinical, structural, and adverse events with quantitative comparisons made before and after implementation of the bundle. Qualitative analysis will be done to evaluate the outcomes of intervention by conducting FGDs with HCPs involved during the implementation process. This will provide an understanding and validation of quantitative findings. Discussion ...
    Keywords FAST-M intervention ; Maternal sepsis ; Pakistan ; Qualitative study ; Sepsis bundle ; Care bundle ; Medicine (General) ; R5-920
    Subject code 650
    Language English
    Publishing date 2022-06-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Evaluation of Expression Level of Apolipoprotein M as a Diagnostic Marker for Primary Venous Thromboembolism.

    Ahmad, Abrar / Sundquist, Kristina / Zöller, Bengt / Dahlbäck, Björn / Elf, Johan / Svensson, Peter J / Strandberg, Karin / Sundquist, Jan / Memon, Ashfaque A

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

    2017  Volume 24, Issue 3, Page(s) 416–422

    Abstract: Recently, decreased levels of apolipoprotein M (ApoM) were shown to be associated with higher risk ...

    Abstract Recently, decreased levels of apolipoprotein M (ApoM) were shown to be associated with higher risk of recurrent venous thromboembolism (VTE) in male patients. However, the role of ApoM in primary VTE is unknown. We aimed in our study to analyze the plasma levels of ApoM in patients with VTE in order to evaluate the diagnostic importance of ApoM in primary VTE. A total of 357 patients with suspected first episode of VTE were recruited prospectively in the SCORE study. Plasma samples from 307 patients were available for quantifying the plasma levels of ApoM in patients with VTE using sandwich enzyme-linked immunosorbent assay method. Among the whole population, plasma levels (mean [standard deviation]) of ApoM were not significantly different between patients with VTE (0.72 [0.20]) and non-VTE patients (0.72 [0.16]), P = .99. Similarly, in regression analyses, no significant association of ApoM plasma levels with the risk of VTE was found on univariate (odds ratio [OR] =1.0, 95% confidence interval [CI] 0.21-4.84, P = .99) and multivariate analysis (OR = 1.25, 95% CI = 0.19-8.34, P = .819) after adjusting for age, body mass index, and smoking. Moreover, results did not differ significantly after stratification of data according to sex ( P > .05). In this study, our results do not suggest a diagnostic role for ApoM plasma levels in patients with primary VTE. Moreover, the current study suggests that role of ApoM as a risk factor may differ for primary VTE and recurrent VTE in male patients.
    MeSH term(s) Adult ; Aged ; Apolipoproteins M/blood ; Female ; Humans ; Male ; Middle Aged ; Recurrence ; Risk Factors ; Sex Factors ; Venous Thromboembolism/blood ; Venous Thromboembolism/diagnosis
    Chemical Substances APOM protein, human ; Apolipoproteins M
    Language English
    Publishing date 2017-09-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1237357-6
    ISSN 1938-2723 ; 1076-0296
    ISSN (online) 1938-2723
    ISSN 1076-0296
    DOI 10.1177/1076029617730639
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The association between apolipoprotein M and insulin resistance varies with country of birth.

    Memon, A A / Bennet, L / Zöller, B / Wang, X / Palmér, K / Dahlbäck, B / Sundquist, J / Sundquist, K

    Nutrition, metabolism, and cardiovascular diseases : NMCD

    2014  Volume 24, Issue 11, Page(s) 1174–1180

    Abstract: ... Levels of apolipoprotein M (ApoM) have been shown to be decreased in T2DM. However, its role in different ...

    Abstract Background and aims: Risk of type 2 diabetes mellitus (T2DM) differs according to ethnicity. Levels of apolipoprotein M (ApoM) have been shown to be decreased in T2DM. However, its role in different ethnicities is not known. We examined the differences in plasma ApoM levels in Swedish residents born in Iraq (Iraqis) and Sweden (Swedes) in relation to T2DM and insulin resistance (IR).
    Methods and results: Iraqis and Swedes, aged 45-65 years residing in Rosengård area of Malmö were randomly selected from census records and underwent an oral glucose tolerance test. Plasma levels of ApoM were quantified in 162 participants (Iraqis, n = 91; Swedes, n = 71) by a sandwich ELISA method. Age-, sex-, and body mass index (BMI) adjusted plasma ApoM levels differed by country of birth, with Swedes having 18% higher levels compared to Iraqis (p = 0.001). ApoM levels (mean ± SD) were significantly decreased in Swedes with T2DM (0.73 ± 0.18) compared to those with normal glucose tolerance (NGT) (0.89 ± 0.24; p = 0.03). By contrast, no significant difference in ApoM levels was found between Iraqis with T2DM (0.70 ± 0.17) and those with NGT (0.73 ± 0.13; p = 0.41). In multivariate linear regression analysis with an interaction term between IR and country of birth, low ApoM levels remained significantly associated with IR in Swedes (p = 0.008), independently of age, sex, BMI, family history of diabetes, HDL, LDL, and triglycerides, but not in Iraqis (p = 0.35).
    Conclusion: Our results show that ApoM levels differ according to country of birth and are associated with IR and T2DM only in Swedes.
    MeSH term(s) Aged ; Apolipoproteins/blood ; Apolipoproteins/genetics ; Apolipoproteins M ; Body Mass Index ; Cholesterol, HDL/blood ; Cholesterol, LDL/blood ; Cross-Sectional Studies ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/ethnology ; European Continental Ancestry Group ; Female ; Glucose Tolerance Test ; Humans ; Insulin/blood ; Insulin Resistance/ethnology ; Iraq/ethnology ; Lipocalins/blood ; Lipocalins/genetics ; Male ; Middle Aged ; Sweden/epidemiology ; Triglycerides/blood
    Chemical Substances APOM protein, human ; Apolipoproteins ; Apolipoproteins M ; Cholesterol, HDL ; Cholesterol, LDL ; Insulin ; Lipocalins ; Triglycerides
    Language English
    Publishing date 2014-11
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1067704-5
    ISSN 1590-3729 ; 0939-4753
    ISSN (online) 1590-3729
    ISSN 0939-4753
    DOI 10.1016/j.numecd.2014.05.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Apolipoprotein M and the risk of unprovoked recurrent venous thromboembolism.

    Memon, Ashfaque A / Sundquist, Jan / Zöller, Bengt / Wang, Xiao / Dahlbäck, Björn / Svensson, Peter J / Sundquist, Kristina

    Thrombosis research

    2014  Volume 133, Issue 3, Page(s) 322–326

    Abstract: Introduction: Apolipoprotein M (ApoM) protects against atherosclerosis; however, it is unknown ...

    Abstract Introduction: Apolipoprotein M (ApoM) protects against atherosclerosis; however, it is unknown whether it also protects against recurrent venous thromboembolism (VTE).
    Material and methods: Patients in the Malmö Thrombophilia Study (MATS) were followed post-anticoagulant treatment until the diagnosis of recurrent VTE or the end of the study (mean follow-up 36 months). Among patients with a first episode of unprovoked VTE, we identified 43 patients (9.7%) with recurrent VTE during the follow-up period. Three age- and sex-matched control subjects without recurrent VTE were selected for each case (n = 129). Plasma levels of ApoM were quantified by a sandwich ELISA method.
    Results: Among all patients, the plasma levels (mean ± SD) of ApoM were not significantly different between patients with recurrent (0.70 ± 0.2) and non-recurrent VTE (0.74 ± 0.2), p = 0.2. However, after stratification of data according to gender, male patients with recurrent VTE showed significantly (p=0.02) lower ApoM levels (0.63 ± 0.2) as compared to those with non-recurrent VTE (0.74 ± 0.2). No significant differences in ApoM levels were found between recurrent (0.8 ± 0.2) and non-recurrent VTE (0.75 ± 0.2) in female patients, p = 0.3. Cox-regression analysis showed that the risk of recurrent VTE was 0.98 (95% CI, 0.96-0.99) for each 0.01 μM increase in ApoM level in male patients (p = 0.042), and this risk remained unchanged after adjusting for inherited thrombophilia and body mass index (p = 0.027). ApoM levels were not associated with the risk of recurrent VTE in female patients.
    Conclusion: Our results show that levels of ApoM in recurrent VTE may differ according to gender and lower levels of ApoM may predict VTE recurrence in male patients.
    MeSH term(s) Anticoagulants/administration & dosage ; Apolipoproteins/blood ; Apolipoproteins M ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Lipocalins/blood ; Male ; Middle Aged ; Recurrence ; Risk Factors ; Sex Factors ; Venous Thromboembolism/blood ; Venous Thromboembolism/pathology
    Chemical Substances APOM protein, human ; Anticoagulants ; Apolipoproteins ; Apolipoproteins M ; Lipocalins
    Language English
    Publishing date 2014-03
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 121852-9
    ISSN 1879-2472 ; 0049-3848
    ISSN (online) 1879-2472
    ISSN 0049-3848
    DOI 10.1016/j.thromres.2013.12.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism.

    Ahmad, Abrar / Sundquist, Kristina / Zöller, Bengt / Dahlbäck, Björn / Svensson, Peter J / Sundquist, Jan / Memon, Ashfaque A

    Thrombosis and haemostasis

    2016  Volume 116, Issue 3, Page(s) 432–441

    Abstract: Apolipoprotein M (ApoM) plasma levels have been reported to be associated with risk ...

    Abstract Apolipoprotein M (ApoM) plasma levels have been reported to be associated with risk of venous thromboembolism (VTE) recurrence. However, the role of genetic alterations in the ApoM gene in VTE recurrence remains unknown. The aim of this study was to identify genetic aberrations in ApoM gene in VTE recurrence and their role in prediction of VTE recurrence in a prospective follow-up study of 1465 VTE patients. During follow-up, 156 (10.6 %) patients had VTE recurrence. First screening of whole ApoM gene was performed by Sanger's sequencing in selected age and sex matched non-recurrent and recurrent patients (n=95). In total six polymorphisms were identified and two polymorphisms (rs805297 and rs9404941) with minor allele frequency (MAF) ≥5 % were further genotyped in the whole cohort by Taqman PCR. ApoM rs805297 polymorphism was significantly associated with higher risk of VTE recurrence in males but not in females on both univariate (p= 0.038, hazard ratio = 1.72, confidence interval = 1.03-2.88) and on multivariate analysis adjusted with mild and severe thrombophilia, family history, location and acquired risk factors for VTE. However, ApoM rs9404941 polymorphism showed no significant association with risk of VTE recurrence in all patients as well as in different gender groups. Moreover, ApoM rs805297 and rs9404941 polymorphisms were not associated with the ApoM plasma levels. In conclusion, for the first time we have sequenced whole ApoM gene in VTE and identified six polymorphisms. ApoM rs805297 was significantly associated with higher risk of VTE recurrence in male but not in female patients.
    Language English
    Publishing date 2016-08-30
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 518294-3
    ISSN 0340-6245
    ISSN 0340-6245
    DOI 10.1160/TH16-03-0178
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: The N-alkyldithiocarbamato complexes [M(S2CNHR)2] (M=Cd(II) Zn(II); R=C2H5, C4H9, C6H13, C12H25); their synthesis, thermal decomposition and use to prepare of nanoparticles and nanorods of CdS.

    Memon, Ashfaq A / Afzaal, Mohammad / Malik, Mohammad A / Nguyen, Chinh Q / O'Brien, Paul / Raftery, Jim

    Dalton transactions (Cambridge, England : 2003)

    2006  , Issue 37, Page(s) 4499–4505

    Abstract: A series of N-alkyldithiocarbamato complexes [M(S2CNHR)2] (M=Cd(II), Zn(II); R=C2H5, C4H9, C6H13 ...

    Abstract A series of N-alkyldithiocarbamato complexes [M(S2CNHR)2] (M=Cd(II), Zn(II); R=C2H5, C4H9, C6H13, C12H25) have been synthesised and characterized. The decomposition of these complexes to sulfates has been investigated, and a mechanism proposed. The structures of [Zn(S2CNHHex)2], [Cd(SO4)2(NC5H5)4)]n and [Cd(SO4)2(NC5H5)2(H2O)2)]n have been determined by X-ray single crystal method. The cadmium complex [Cd(S2CNHC12H25)2] and zinc complex [Zn(S2CNHC6H13)2] were used as single-source precursors to synthesize CdS and ZnS nanoparticles, respectively. The synthesis of CdS nanoparticles was carried under various thermolysis conditions and changes in the shape of derived nanoparticles were studied by transmission electron microscope (TEM).
    Language English
    Publishing date 2006-10-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 1472887-4
    ISSN 1364-5447 ; 1477-9234 ; 1477-9226 ; 0300-9246
    ISSN (online) 1364-5447 ; 1477-9234
    ISSN 1477-9226 ; 0300-9246
    DOI 10.1039/b606661e
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: The association between apolipoprotein M and insulin resistance varies with country of birth

    Memon, A.A / B. Dahlbäck / B. Zöller / J. Sundquist / K. Palmér / K. Sundquist / L. Bennet / X. Wang

    Nutrition, metabolism, and cardiovascular diseases. 2014 Nov., v. 24, no. 11

    2014  

    Abstract: Risk of type 2 diabetes mellitus (T2DM) differs according to ethnicity. Levels of apolipoprotein M ...

    Abstract Risk of type 2 diabetes mellitus (T2DM) differs according to ethnicity. Levels of apolipoprotein M (ApoM) have been shown to be decreased in T2DM. However, its role in different ethnicities is not known. We examined the differences in plasma ApoM levels in Swedish residents born in Iraq (Iraqis) and Sweden (Swedes) in relation to T2DM and insulin resistance (IR).Iraqis and Swedes, aged 45–65 years residing in Rosengård area of Malmö were randomly selected from census records and underwent an oral glucose tolerance test. Plasma levels of ApoM were quantified in 162 participants (Iraqis, n=91; Swedes, n=71) by a sandwich ELISA method.Age-, sex-, and body mass index (BMI) adjusted plasma ApoM levels differed by country of birth, with Swedes having 18% higher levels compared to Iraqis (p=0.001). ApoM levels (mean±SD) were significantly decreased in Swedes with T2DM (0.73±0.18) compared to those with normal glucose tolerance (NGT) (0.89±0.24; p=0.03). By contrast, no significant difference in ApoM levels was found between Iraqis with T2DM (0.70±0.17) and those with NGT (0.73±0.13; p=0.41). In multivariate linear regression analysis with an interaction term between IR and country of birth, low ApoM levels remained significantly associated with IR in Swedes (p=0.008), independently of age, sex, BMI, family history of diabetes, HDL, LDL, and triglycerides, but not in Iraqis (p=0.35).Our results show that ApoM levels differ according to country of birth and are associated with IR and T2DM only in Swedes.
    Keywords body mass index ; cardiovascular diseases ; diabetes ; enzyme-linked immunosorbent assay ; glucose tolerance ; glucose tolerance tests ; high density lipoprotein ; insulin resistance ; low density lipoprotein ; nationalities and ethnic groups ; regression analysis ; risk ; triacylglycerols ; Iraq ; Sweden
    Language English
    Dates of publication 2014-11
    Size p. 1174-1180.
    Publishing place Elsevier B.V.
    Document type Article
    ZDB-ID 1067704-5
    ISSN 0939-4753
    ISSN 0939-4753
    DOI 10.1016/j.numecd.2014.05.007
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article: Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism

    Ahmad, Abrar / Sundquist, Kristina / Zöller, Bengt / Dahlbäck, Björn / Svensson, Peter J. / Sundquist, Jan / Memon, Ashfaque A.

    Thrombosis and Haemostasis

    2016  Volume 116, Issue 09, Page(s) 432–441

    Abstract: Apolipoprotein M (ApoM) plasma levels have been reported to be associated with risk ...

    Abstract Apolipoprotein M (ApoM) plasma levels have been reported to be associated with risk of venous thromboembolism (VTE) recurrence. However, the role of genetic alterations in the ApoM gene in VTE recurrence remains unknown. The aim of this study was to identify genetic aberrations in ApoM gene in VTE recurrence and their role in prediction of VTE recurrence in a prospective follow-up study of 1465 VTE patients. During follow-up, 156 (10.6 %) patients had VTE recurrence. First screening of whole ApoM gene was performed by Sanger’s sequencing in selected age and sex matched non-recurrent and recurrent patients (n=95). In total six polymorphisms were identified and two polymorphisms (rs805297 and rs9404941) with minor allele frequency (MAF) ≥5 % were further genotyped in the whole cohort by Taqman PCR. ApoM rs805297 polymorphism was significantly associated with higher risk of VTE recurrence in males but not in females on both univariate (p= 0.038, hazard ratio = 1.72, confidence interval = 1.03–2.88) and on multivariate analysis adjusted with mild and severe thrombophilia, family history, location and acquired risk factors for VTE. However, ApoM rs9404941 polymorphism showed no significant association with risk of VTE recurrence in all patients as well as in different gender groups. Moreover, ApoM rs805297 and rs9404941 polymorphisms were not associated with the ApoM plasma levels. In conclusion, for the first time we have sequenced whole ApoM gene in VTE and identified six polymorphisms. ApoM rs805297 was significantly associated with higher risk of VTE recurrence in male but not in female patients. Supplementary Material to this article is available online at www.thrombosis-online.com.
    Keywords Apolipoprotein M ; recurrent VTE ; multivariate analysis
    Language English
    Publishing date 2016-01-01
    Publisher Schattauer GmbH
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 518294-3
    ISSN 2567-689X ; 0340-6245
    ISSN (online) 2567-689X
    ISSN 0340-6245
    DOI 10.1160/TH16-03-0178
    Database Thieme publisher's database

    More links

    Kategorien

To top